DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Poordad F, Kowdley KV et al.
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C / C patients with chronic hepatitis C genotype 1.
Journal of hepatology 2013;
59: 18-23
We do not assume any responsibility for the contents of the web pages of other providers.